Efficacy and Safety of Risankizumab in the Treatment of Crohn's Disease of the Pouch-Reference-Cited by-同舟云学术

Efficacy and Safety of Risankizumab in the Treatment of Crohn's Disease of the Pouch

Published:2024-08-29 Issue:9 Volume:11 Page:e01476
ISSN:2326-3253
Container-title:ACG Case Reports Journal
language:en
Short-container-title:ACG Case Rep J

Author:

Lan Nan¹,Shen Bo²^ORCID

Affiliation:

1. Division of Digestive and Liver Diseases, Columbia University Irving Medical Center–New York Presbyterian Hospital, New York, NY

2. Center for Inflammatory Bowel Disease, Columbia University Irving Medical Center–New York Presbyterian Hospital, New York, NY

Abstract

ABSTRACT Risankizumab has shown efficacy in the treatment of moderate-to-severe Crohn's disease (CD). The use of risankizumab in the treatment of CD of the pouch has not been previously reported. Here, we have 10 patients with biologics exposed CD of the pouch treated with risankizumab. Some patients showed endoscopic improvement regarding inflammation with minimal clinical improvement. Our findings warrant further study to validate the efficacy and safety of risankizumab in the treatment of CD of the pouch.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. Diagnosis and classification of ileal pouch disorders: Consensus guidelines from the International Ileal Pouch Consortium;Shen;Lancet Gastroenterol Hepatol.,2021

2. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: Consensus guidelines from the International Ileal Pouch Consortium;Shen;Lancet Gastroenterol Hepatol.,2022

3. Risankizumab as induction therapy for Crohn's disease: Results from the phase 3 ADVANCE and MOTIVATE induction trials;D'Haens;Lancet.,2022

4. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: Results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial;Ferrante;Lancet.,2022

5. Pouchitis after ileal pouch-anal anastomosis: A Pouchitis Disease Activity Index;Sandborn;Mayo Clin Proc.,1994